Hiroyuki Kagechika spends much of his time researching Stereochemistry, Retinoic acid, Retinoid X receptor, Retinoic acid receptor and Retinoid. His Stereochemistry research is multidisciplinary, incorporating perspectives in Biological activity, Benzoic acid, Molecule and Amide. Hiroyuki Kagechika has researched Retinoic acid in several fields, including Receptor, Ligand, Mechanism of action and Cell biology.
Retinoid X receptor is a subfield of Biochemistry that Hiroyuki Kagechika tackles. His Retinoic acid receptor research is multidisciplinary, relying on both Interleukin 12 and Cancer research. His Retinoid research is multidisciplinary, incorporating elements of Substituent and Pharmacology.
His primary areas of study are Stereochemistry, Retinoic acid, Retinoid, Biochemistry and Retinoid X receptor. His Stereochemistry research includes elements of Benzoic acid, Molecule and Amide. His research integrates issues of Receptor, Cellular differentiation and Cell biology in his study of Retinoic acid.
The study incorporates disciplines such as Cancer research, In vitro and Pharmacology in addition to Retinoid. The concepts of his Biochemistry study are interwoven with issues in Cell culture and Leukemia. His biological study spans a wide range of topics, including Agonist, Endocrinology, Retinoid X receptor alpha and Internal medicine.
His primary areas of investigation include RYR1, Cell biology, Cancer research, Pharmacology and Ryanodine receptor. His work carried out in the field of Cell biology brings together such families of science as Secretion, High-throughput screening and Retinoic acid. His research in High-throughput screening tackles topics such as Characterization which are related to areas like Biochemistry.
His study in Retinoic acid is interdisciplinary in nature, drawing from both Babylonia japonica, Retinoid X receptor and Raf kinase. His work is dedicated to discovering how Cell growth, Scaffold protein are connected with Retinoid and other disciplines. His research in Stereochemistry intersects with topics in Binding affinities and Transactivation.
His main research concerns Cancer research, Antagonist, Cell biology, Progesterone receptor and Endoplasmic reticulum. His Cancer research research is multidisciplinary, incorporating elements of Cancer, Epithelial cell adhesion molecule, Cell culture, Stem cell and Androgen receptor. The concepts of his Antagonist study are interwoven with issues in Triazine, 1,3,5-Triazine, IC50, Stereochemistry and Pharmacology.
His Cell biology study integrates concerns from other disciplines, such as Prostaglandin E2, Receptor, Cell growth and Secretion. His MAPK/ERK pathway study combines topics in areas such as Binding domain and Retinoic acid. His work on Retinoid as part of general Retinoic acid study is frequently linked to Hormone response element, bridging the gap between disciplines.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Tokyo
University of Tokyo
Tokushima Bunri University
Tokyo Medical and Dental University
Tokyo Medical and Dental University
Jichi Medical University
Chiba University
University of Minnesota
University of Tokyo
RIKEN Center for Integrative Medical Sciences